World Biomarkers & Diagnostics Series

Since 2010, the World Biomarkers & Diagnostics Series has been at the centre of the biomarker and diagnostic community, gathering thought leaders and pioneers in the biomarker, CDx and precision medicine fields.

Providing a much-needed platform for candid conversations on how to define, adopt and implement a CDx strategy to ensure your drug candidates are regulatory compliant, achieve reimbursement and gain market share, the event series is dedicated to helping to bring the right drug, to the right patient, at the right time.

As pharma, biotech, diagnostic and technology providers strive to develop more safe and effective precision medicine products that better target patient responders, join our industry-leading meetings to discover and translate novel predictive biomarker signatures into clinically validated companion diagnostic assays for their precision medicine candidates.